Empowering The Executive to Make Data-based Decisions
Manufacturing in today's biopharmaceutical industry is undergoing a massive transformation. Competition is increasing, margins are shrinking and improvement initiatives together with tightening regulatory requirements and greater government scrutiny are seemingly adding greater burden to manufacturing organizations.
Browse the resources below to learn how the Dassault Systèmes 3DEXPERIENCE platform is enabling pharmaceutical companies to deliver on the promise of providing highly effective medicines when and where needed.
- Data-based decisions for effectively improving processes and products
- Efficient collaboration for optimized operations throughout the enterprise
- Virtualization and simulation for more predictive and agile operations
- Real-time visibility and access to critical KPIs and CQAs
Preparing for the Growth of the Biopharma Market
The future looks bright for the biologic manufacturing market. But the challenge will be to ensure product quality and efficacy. Learn how leading companies are meeting these challenges by using a state-of-the-art manufacturing platform to improve quality, reduce cost and minimize patient risk.
Tackle Manufacturing Data Challenges
See how limited visibility of process and quality data are impacting pharmaceutical manufacturing performance and regulatory compliance and how the comprehensive manufacturing data analytics solution provided by Dassault Systèmes can help.
Customer Story: Maximizing Product Throughput
Read how Pacira has been able to improve process understanding, optimize their manufacturing processes and realize significant savings in scrap avoidance by implementing BIOVIA Discoverant in Tech Transfer and early commercialization.
Frost & Sullivan Report: Data-driven Solutions Transforming the Global Biologics Manufacturing
Analytics are no longer a "nice to have" in manufacturing operations. Manufacturing line-of-business and IT roles have to rapidly develop a plan to go beyond reporting and create analytical capabilities that can predict and prescribe production's flexibility and reliability.
Frost & Sullivan/Dassault Systèmes Presentation: The Promise of Biologics Manufacturing
Biologics have enormous potential to drive further growth in the biopharmaceutical market. However to become successful, organizations must leverage new technology, and process, that streamlines upstream and downstream manufacturing technologies. Watch this presentation to learn how your organization can develop the core competencies needed to bring breakthrough therapies to market faster.
Life Science Manufacturing and Quality: The New Path to Performance
Learn how moving the quality focus from regulatory compliance to effectively connecting and assessing current adoption of identified best practices quality management and operations can help life science organizations improve corporate operational and financial performance.